220 likes | 352 Views
9th Consortium Meeting. WP 1.3 Quality and assessment. Hans-Peter Eich. Coordination Centre for Clinical Trials, Heinrich-Heine-University, Düsseldorf, Germany. www.infobiomed.net. Rome, Italy, September 14 to 15, 2006. Objectives for evaluation. Objectives
E N D
9th Consortium Meeting WP 1.3 Quality and assessment Hans-Peter Eich Coordination Centre for Clinical Trials, Heinrich-Heine-University, Düsseldorf, Germany www.infobiomed.net Rome, Italy, September 14 to 15, 2006
Objectives for evaluation • Objectives • Assessment of results obtained within the single work packages, especially WP 6 (pilot application) • Specific objectives • Assessment of the validity of tools and methodologies used • Assessment of functionality and user-interface • Potential use • Evaluation of network www.infobiomed.net Rome, Italy, September 14 to 15, 2006
Overview on evaluation tasks www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP1.3 Quality and assessment www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP1.3 Quality and assessment 1. Three types of interaction between partners 2. Merging all types of information 3. Detection of clusters within strong interaction between partners www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP2 Dissemination & Communication www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP2 Dissemination & Communication www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP2 Dissemination & Communication www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP3 Training & Mobility www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP3 Training & Mobility www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP3 Training & Mobility www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.1 Pharmainformatics I www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.1 Pharmainformatics II www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.1 Pharmainformatics III filtering list by ATC codes List of NFB targets 204 ATC codes Removal of Drugs for Topic Use and Rank List by Frequency in case-control set Rank by potency against pathway 127 ATC codes Final List of Drugs Relative Risk Assessment Novel or classical approach ? New Treatment Options for CRPS www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.2 Genomics and microbiology I www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.2 Genomics and microbiology II www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.2 Genomics and microbiology III Core interferon genes/ 200 CMV proteins Protein Interaction prediction (PIANA) Potential biomarker Drugability analysis predicted biomarker Novel or classical approach? www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.3 Genomics and chronic inflammation I www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.4 Genomics and colon cancer I www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.4 Genomics and colon cancer II www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.4 Genomics and colon cancer II www.infobiomed.net Rome, Italy, September 14 to 15, 2006
WP 6.4 Genomics and colon cancer II www.infobiomed.net Rome, Italy, September 14 to 15, 2006